Protein Sciences
Appearance
Protein Sciences Corporation is a biotech company based in Meriden, Connecticut. The company develops and produces vaccines and biopharmaceuticals for use against influenza and other diseases. Protein Sciences has developed a novel method for vaccine production, using a genetically modified baculovirus that is allowed to reproduce in insect cells.[1][2] This method reduces the lead time for vaccine production to six to eight weeks, considerably shorter than the conventional, egg-based, method.[3] The company has applied for a Biologic License Application with the FDA for FluBlok, their seasonal influenza vaccine[4][5].
References
- ^ Journal of the American Medical Association, Vol. 297:Safety and Immunogenicity of a Baculovirus-Expressed Hemagglutinin Influenza Vaccine
- ^ The NIH Biomedical Research Response to Influenza
- ^ NBC Connecticut:Swine Flu Vaccine Could Be Ready in 6 Weeks
- ^ The Wall Street Journal:FDA Panel to Consider New Flu Vaccine Technology
- ^ FluBlok, (Influenza Vaccine, Recombinant Hemagglutinin), Briefing Document, FDA Vaccines and Related Biological Products Advisory Committee Meeting, November 19, 2009